CGNNT(SZ:000881)2024-07-09 10:29Financial Performance - The estimated net profit for the first half of 2024 is expected to be a loss between 75 million and 100 million yuan, compared to a loss of 104.68 million yuan in the same period last year[1]. - The estimated net profit after deducting non-recurring gains and losses is expected to be a loss between 110 million and 145 million yuan, compared to a loss of 147.04 million yuan in the same period last year[1]. - The basic earnings per share is expected to be a loss between 0.0793 yuan and 0.1058 yuan, compared to a loss of 0.1107 yuan in the same period last year[1]. - The performance forecast has not been audited by registered accountants, and specific financial data will be confirmed in the company's 2024 semi-annual report[2][5]. Business Strategy - The company is focusing on its "A+" strategy to enhance product research and manufacturing, optimize industry structure, and expand business scope[3]. Business Segments - The new materials business has seen stable market share and slight year-on-year sales growth, but lower product prices in the cable and telecommunications sectors have impacted gross margins[3]. - The medical health business is still in the cultivation phase, with ongoing investments aimed at promoting localization and autonomy, but it has not yet achieved profitability[3]. - The electronic beam treatment special waste business is in the market introduction and promotion phase, with expected losses due to increased efforts in promoting demonstration projects[3].